Hope or Hype?: The importance of Multimodal Data Integration to Advance Precision Medicine
About
This panel discussion took place at BioData World Congress in Basel, Switzerland on 09 November.
Data integration and AI/ML are seemingly everywhere and are increasingly recognized as critical to accelerating the advancement of precision medicine.
Healthcare institutions and BioPharma companies aim to make more informed decisions by combining a diversity of data modalities with the longitudinal follow-up of patients from diagnosis to treatment and outcomes, with the goal of better understanding the patient journey and identifying optimal subpopulations for care.
Disclaimer notice: The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.
The opinions expressed during this presentation are these of the speaker and may not represent the opinions of SOPHiA GENETICS.
SOPHiA GENETICS does not provide support in the validation of custom products for clinical use.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at support@sophiagenetics.com to obtain the appropriate product information for your country of residence.
on-demand webinar
Agenda
The essential questions addressed in this on-demand webinar include the following:
1) How can this approach be applied on a large scale?
2) Who will benefit from these technologies?
3) How can we move from R&D to clinical practice today and in the future?
4) How will these algorithmic approaches impact or guide decision-making?
5) Do we promise the impossible, or is there hope for validated, multimodal data analysis?
Presenters
Peter Casasanto, MS, MBA
Chief BioPharma Officer, SOPHiA GENETICS
David Dellamonica, MBA
Head, Digital and Innovation, Oncology, Europe & Canada, AstraZeneca
Michael G. Frank, MBA
Digital Ventures Lead, Memorial Sloan Kettering Cancer Center (MSKCC)
Prof. Jacques Cadranel, MD
Oncologist, Pneumology Service, Assistance Publique – Hôpitaux de Paris, France